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ABSTRACT 
The aim of the present work is fabrication of Curcumin encapsulated microbeads from Sodium Alginate/Polyethylene Glycol/Kaoli n using 
glutaraldehyde as crosslinker by simple ionotropic gelation technique. The developed microbeads were characterized by Fourier transform 
infrared spectroscopy to confirm the formation of microbeads. Differential scanning calorimetry and X-ray diffraction studies have confirmed 
uniform molecular dispersion of CUR in the microbeads. Encapsulation efficiency of CUR in microbeads was ranged from 40 to 49 %. Dynamic 
swelling studies and in vitro release kinetics were performed in simulated intestinal fluid (pH 7.4) and simulated gastric fluid (pH 1.2) at 37 oC. 
The results suggest that both swelling studies and cumulative release studies were depend on pH of the test medium, which might be suitable 
for intestinal drug delivery. The in vitro release data were analysed by using Korsmeyer peppas equation to compute the diffusion exponent (n); 
the results suggest that it followed non-Fickian diffusion. 
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1. INTRODUCTION 
During the last few years, a wide range of clay minerals have 
been used in pharmaceutical and biomedical fields 
exclusively for controlled drug delivery systems. Clay 
minerals are the oldest earth material composed of 
hydrous aluminium phyllosilicates which are usually formed 
as a product of chemical weathering of other silicate 
minerals at the surface of the earth1. Clay minerals are 
widely employed in the pharmaceutical industry as a 
lubricant, flavour correctors, desiccants, disintegrants, 
diluents, binders, pigments and opacifiers2,3. Clay minerals 
used as oral treatment of diarrhea and also for topical 
dermatological applications4,5. Clay minerals act as an active 
ingredient in pharmaceutical formulations because it can 
control the efficiency and consistency in dosage formulations 
and also improve the bioavailability because of their larger 
specific surface area and considerable ion-exchange capacity 
which attribute to their ability to control the efficiency of bio 
active molecules. Kaolin is a hydrated a two-dimensional 
(2D) aluminosilicate mineral6,7. It has been extensively used 
in biomedical related applications such as an activating agent 
for blood clotting8, as an ingredient for operation 
haemostasis9 and also used in drug delivery systems for 
prolonged release, especially of basic drugs because it can 
acts as active excipient in pharmaceutical dosage forms to 
increase the efficiency and bioavailability of drug 
molecules10. 
Sodium alginate (SA) is a natural polysaccharide comprising of Ⱦ-D-mannuronic acid (M) and Ƚ-L-guluronic acid (G) repeating units linked by ͳ→4 linkage and displayed in the 
form of homo-polymeric (MMMM or GGGG blocks) and 
hetero-polymeric sequences (MGMGMG or GMGMGM 
blocks)11. Alginates have been used in pharmaceutical 
applications as a binder, viscosity modifying agent, stabilizer, 
tablet disintegrant and thickening agent. Alginates possess 
mucoadhesive biomaterial which could show a potential 
advantage in mucosal drug delivery due to its 
cytocompatibility, biocompatibility and biodegradation12,13. 
Advantage of alginates is used as a matrix for the fabrication 
of controlled and sustained release formulations because it is 
degraded and absorbed by the body during and after release 
of drug molecules without any toxic effects14. Therefore 
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alginate is a suitable matrix for sustained release of various 
drug molecules. 
Poly Ethylene Glycol (PEG) is one of the most used polymer 
in emerging field of polymer based drug delivery. PEG is a 
widely used biomaterial due to its hydrophilicity, 
biocompatibility, and elimination via both renal and hepatic 
pathways15. PEG used as an inactive ingredient in the 
pharmaceutical industry as lubricants for medical devices, 
plasticizer, and as vehicles in dermatological applications 
suppositories, ointment and tablets16,17. Bendels et al. has 
reported that PEG showed elevated permeability in weak 
acids and neutral compounds but lowered permeability in 
weak bases18. Therefore, PEG has great profound influences 
on the intestinal absorption and systemic exposure of oral 
drugs. Hence PEG has been used in various applications such 
as drug delivery19, tissue engineering20 and in regenerative 
medicine21. 
Curcumin is a yellow bioactive compound extracted from the 
rhizome of turmeric (Curcuma longa)22, possesses a wide 
range of pharmacological exploits including anti-
inflammatory23, anti-oxidant24, antimicrobial25, 
antirheumatic26, thrombosis suppressing27 and also it 
enhance anti-tumour activity against different types of 
cancer cells, including cancers of the colon, prostate, and 
breast28,29. Its biomedical applications are limited due to its 
poor solubility and rapid metabolism, which results in poor 
bioavailability. So, the main aim of the present study is to 
increase the bioavailability and encapsulation efficiency of 
curcumin, for this we have fabricated Kaolin intercalated 
Sodium Alginate/Polyethylene Glycol blend microbeads 
(Scheme 1). The developed microbeads were analysed by 
different techniques such as FTIR, XRD, DSC, TGA and SEM. 
Dynamic swelling studies and drug release kinetics were 
investigated in both simulated intestinal fluid (pH 7.4) and 
simulated gastric fluid (pH 1.2) at 37 oC and the results has 
been addressed. 
 
 
Scheme 1. Schematic representation of SA/PEG/KA blend IPN microbeads 
 
EXPERIMENTAL 
2.1. Materials 
Kaolin was purchased from Sigma–Aldrich (USA). Sodium 
alginate, Polyethylene Glycol, Glutaraldehyde and Calcium 
Chloride, were purchased from Sd.Fine Chemicals, Mumbai, 
India. Curcumin was purchased from Loba Chemicals, 
Mumbai, India. Water used was of high purity grade after 
double distillation. 
2.2. Preparation of Sodium Alginate/Mmt Microbeads: 
Varying amounts of SA and PEG (as per given in Table 1) 
were weighed and dissolved in water under constant stirring 
overnight. To this solution, required amounts of Kaolin and 
Glutaraldehyde (as per given in Table 1) were added and 
stirred well. A required amount of Curcumin was added and 
stirred to obtain a homogeneous solution. Afterwards the 
suspension was placed 5mins for sonication to get 
homogenous suspension. There after the resulting 
suspension was slowly dropped into CaCl2 solution, where 
the spherical beads formed instantly were kept for 40 min. 
The obtained wet beads were collected by decantation, 
washed three times with double distilled water to remove 
the drug attached on the bead surface, and finally were dried 
in air overnight at room temperature. 
 
Table 1. Formulation and composition of all samples 
Formulation 
code 
SA  
(mg) 
PEG 
(mg) 
Distilled 
Water 
(mL) 
Drug 
(mg) 
GA 
(mL) 
Kaolin 
(mg) 
SP1 400 00 20 100 1 000 
SP2 320 80 20 100 1 000 
SP3 280 120 20 100 1 000 
SP4 320 80 20 100 1 200 
SP5 320 80 20 100 1 400 
SP6 320 80 20 100 1 600 
SP7 320 80 20 00 1 000 
 
 
2.3. Characterizations Methods  
2.3.1 Intercalation kinetics 
To find out the maximum time required of CUR for 
intercalation with KA, intercalation kinetics experiment was 
performed. Weighed accurately 50 mg of CUR and 100 mg of 
KA, were dissolved in 20 mL of double distilled water with 
continuous stirring at 37 oC. At predetermined time intervals 
i.e., 0.25, 0.5, 1, 2, 4, 6, 8, 10, 14 hr, the drug solution was 
filtered and concentration of CUR was assayed by using UV spectrophotometer at fixed ɉ-max value of 470.00 nm.  
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2.3.2. Fourier Transform Infrared (FTIR) Spectral 
Analysis 
Fourier-Transmission IR (FT-IR) spectra of PEG, SA, CUR, KA, 
Placebo microbeads, drug loaded SA/PEG microbeads and  
drug loaded SA/PEG/KA microbeads were measured as 
pellets in KBr with a FT-IR spectrophotometer (model 
Bomem MB-3000, with Horizon MBTM FTIR software) in the 
wavelength range of 400–4000 cm-1 to find out the possible 
chemical interactions between polymers and drug. 
2.3.3. Differential Scanning Calorimetry (DSC) 
DSC curves of CUR, Placebo microbeads, and drug loaded 
SA/PEG microbeads were recorded using Thermogravimetry 
analyzer Rheometric Scientific, Model DSC-SP, UK. The 
analysis was performed by heating the sample from 40 to 
600 °C at the heating rate of 10oC/min under nitrogen 
atmosphere.  
2.3.4. Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis of CUR, KA, Placebo microbeads, 
drug loaded SA/PEG microbeads and drug loaded 
SA/PEG/KA microbeads were carried out using 
Thermogravimetry analyzer Rheometric Scientific, Model 
DSC-SP, UK. About 12-14 mg of sample was placed into 
alumina crucible and the thermo grams were recorded 
between 40oC to 600oC at a heating rate of 10oC/min under 
nitrogen atmosphere.  
2.3.5. X-Ray Diffraction (XRD) Analysis 
The X-ray diffraction of  pristine CUR, placebo microbeads, 
and drug loaded SA/PEG microbeads were performed by a 
wide angle X-ray scattering diffractometer (Panalytical X-ray 
Diffractometer, model-X’pert ProȌ with CuKȽ radiation ȋɉ= 
1.54060) at a scanning rate of 10°/min to determine the 
crystallinity. 
2.3.6. Scanning Electron Microscopy (SEM) Analysis 
The topographical structure of microbeads was observed by 
using SEM (JOEL MODEL JSM 840A) with an accelerated 
voltage of 20 kV equipped with an EDAX detector. 
2.3.7. Swelling behaviour 
The swelling behaviour of different formulations was 
determined gravimetrically in simulated intestinal fluid (pH 
7.4) and simulated gastric fluid (pH 1.2) at 37 oC. For this, 
40mg of dry beads were suspended in 30ml of the buffer 
solutions at 37°C and their weight change was examined at 
different time intervals. This process is continued until the 
weight of swollen beads reached constant value. The % 
swelling degree was calculated by the following equation: 
% swelling degree = 
                   –                                       x 100 
2.4. Encapsulation Efficiency 
To investigate the encapsulation efficiency of CUR, a known 
mass of drug loaded microbeads (50mg) were immersed into 
100mL of phosphate buffer solution (pH 7.4 containing 5% 
absolute ethyl alcohol) for 24 hr and then crushed the beads 
to ensure the complete extraction of CUR from the 
microbeads and filtered through filter paper. The filtered 
drug solution was assayed by ultraviolet spectrophotometer at the ɉ-max of 470.00 nm with placebo microbeads were 
used as a blank correction. Concentration of drug was 
determined by using calibration curve constructed by series 
of CUR standard solutions. Percentage of encapsulation 
efficiency was determined by the following formula. 
 
%EE = 
                ሺ  ሻ                 ሺ  ሻ                ሺ  ሻ        
2.5. In Vitro Drug Release Studies 
In vitro drug release studies were carried out by using a 
dissolution tester apparatus (Lab India, Mumbai, India) 
equipped with eight baskets at 37oC. Weighed 100 mg of the 
CUR loaded microbeads were taken in a dialysis bags for the 
drug release studies. The % release of CUR from microbeads 
was carried out in 900 mL of phosphate buffer solution 
pH7.4 and pH 1.2 at a rotation speed of 50 rpm to replicate 
intestinal and gastric fluid atmosphere respectively. At 
regular intervals of time, 5 mL aliquot samples were 
withdrawn, and analyzed using UV spectrophotometer at fixed ɉ-max value of 470.00 nm. After sample withdrawn, the 
same amount of fresh buffer at the same temperature was 
added to the release medium to maintain the sink condition. 
The released drug amount was obtained by using 
concentration versus absorbance calibration curve. 
3.0. RESULTS AND DISCUSSIONS 
3.1. Intercalation kinetics 
Fig. 1 shows the intercalation kinetics of CUR with KA. From 
the results of intercalation kinetics, it was concluded that 
16.93% of CUR was intercalated with KA through 
electrostatically within 2 hr and remains constant up to 14 
hr. Therefore we should keep 2 hr time for intercalation of 
CUR with KA to avoid partial interaction. 
 
Fig. 1. Effect of time for Intercalation of CUR with KA 
3.2. FTIR Spectral Analysis 
The formation of microbeads was confirmed by FTIR 
spectroscopy. FTIR spectra of pure KA (a), SA (b), PEG (c), 
CUR (d), placebo micro beads (e), drug loaded SA/PEG micro 
beads (f) and drug loaded SA/PEG/KA micro beads (g) were 
represented in Fig. 2. The FTIR spectra of KA (Fig. 2a) shows 
a characteristic peaks at 3688 and 3625 cm-1 corresponds to 
O – H stretching frequency of Si – OH and Al – OH 
respectively, a peak at 3456 cm-1 assigned to H – O – H 
stretching frequency of interlayer water, peak at 2360 cm-1 
was attributed to C – H stretching frequency, peak at 1596 
cm-1 corresponds to O – H adsorbed water, the absorption 
bands at 1126 and 902 cm-1 corresponds to Si – O – Si 
stretching band [30]. The prominent peaks for SA (Fig. 2b) 
were 3416 cm-1 for O-H stretching frequency, 1388 cm-1 and 
1612 cm-1 for the asymmetric and symmetric stretching 
frequency of carboxylate group C – O respectively. The FTIR 
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spectra of PEG (Fig. 2c) shows a characteristic absorption 
bands at 3464, 2877, 1469, 1350 and 1108 cm-1 corresponds 
to O – H stretching frequency, C – H stretching frequency, C – 
H bending, O – H bending and C – C, C – O stretching 
frequency respectively31. The FTIR spectra of CUR (Fig. 2d) 
shows a characteristic broad peak at 3496 cm-1 assigned to 
phenolic O–H stretching vibrations, a band at 2923 cm-1 
corresponds to aromatic C–H stretching vibrations, a band at 
1594 cm-1 for stretching vibration of benzene ring skeleton, a 
band at 1511 cm-1 corresponds to mixed (C=O) and (C=C) 
vibration, a band at 1272 cm-1 assigned to Ar-O stretching 
vibrations32. 
The FTIR spectra of placebo microbeads (Fig. 2e) shows a 
band at 1587 cm-1, whereas no such peak was observed in SA 
and PEG, confirmed the interaction between SA and PEG and 
also a band at 1066 cm-1 indicates the formation of 
microbeads. On comparing the FTIR spectra of placebo 
microbeads and drug loaded SA/PEG microbeads (Fig. 2f), 
the band at 1587 cm-1 in placebo microbeads was shifted to 
1596 cm-1 in drug loaded SA/PEG microbeads, which 
confirmed that the drug interacts with the polymer matrix. 
The FTIR spectra of drug loaded SA/PEG/KA microbeads 
(Fig. 2g) shows characteristic bands similar to drug loaded 
SA/PEG microbeads, but the O – H stretching frequency was 
decreased due to interaction of KA with active sites of 
polymer molecules and also a new band appears at 902 cm-1, 
which confirmed that the KA intercalates with active sites of 
polymer matrices and drug molecules33. 
 
 
Fig.2. FTIR spectrum of pure KA (a), SA (b), PEG (c), CUR (d), placebo micro beads (e), drug loaded SA/PEG micro beads (f) and 
drug loaded SA/PEG/KA micro beads (g). 
 
3.3. DSC Analysis 
DSC thermograms of pure CUR (a), placebo microbeads (b) 
and drug loaded SA/PEG microbeads (c) are displayed in Fig. 
3. The drug CUR (Fig. 3a) shows a sharp peak at 189 oC due 
to polymorphism and melting, but in the case of drug loaded 
SA/PEG microbeads (Fig. 3c) no such peak was observed at 
189 oC, suggesting that the drug was uniformly dispersed in 
polymer matrices at molecular level. 
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Fig.3. DSC curves of pure CUR (a), placebo microbeads (b) 
and drug loaded SA/PEG microbeads (SP3 Formulation) (c) 
3.4. TGA Analysis 
Fig. 4 shows the thermograms of Pure CUR (a), placebo 
microbeads (b), drug loaded SA/PEG microbeads (SP3 
Formulation) (c), drug loaded SA/PEG/KA microbeads (d) 
and KA (e). The thermogram of KA (Fig. 4e), shows first 
mass los at 20-200 oC is due to moisture loss, the major 
weight loss step of KA was found in between the region of 
450-600 oC is due to dehydroxylation of Kaolin and continue 
up to 900 oC to produce metakaolin. From the Fig. 4a, it was 
observed that the CUR curve should stable up to 169 oC and 
then its starts mass loss and being maximum at 393 oC due 
to total degradation of the compound. The thermal 
decomposition of placebo microbeads (Fig. 4b) follows three 
steps. The first weight loss step was found in between 40-
187 oC with mass loss of 18% is due to the evaporation of 
adsorbed water. The second weight loss step was observed 
in between the region of 188-290 oC with mass loss of 14% 
due to the degradation of sodium alginate, followed by the 
mass loss of 10% in the region of 291-444 oC due to 
degradation remaining polymer network. In the case of drug 
loaded SA/PEG microbeads (Fig. 4c), the thermal 
decomposition follows four steps. The first mass loss of 17 % 
is observed in the region of 40-184 oC is due to the loss of 
moisture from the network. The second weight loss step was 
found in the region of 190-205 oC with mass loss of 11% due 
to the degradation of SA. The third weight loss of 11% in the 
region of 207-286 oC due to degradation of CUR and the last 
step was found in the region of 290-600 oC with the weight 
loss of 15% due to degradation of remaining polymer 
network. The thermal degradation of drug loaded 
SA/PEG/KA microbeads (Fig. 4d) follows four consecutive 
steps. The first with weight loss of 26% was found in the 
region of 40-182 oC due to the evaporation of adsorbed 
water in polymer network. The second and third step with 
weight loss of 10% and 9% in the region of 187-203 oC and 
206-285 oC respectively is due to the degradation of SA and 
CUR. The final step was found in the region of 287-6200 oC 
with mass loss of 13% is ascribed to the degradation of 
remaining polymer network. From the results of TGA, it was 
concluded that drug loaded SA/PEG/KA polymer network 
shows an overall improvement in the thermal stability of 
microbeads. 
 
Fig.4. TGA curves of Pure CUR (a), placebo microbeads (b), 
drug loaded SA/PEG microbeads (SP3 Formulation) (c), drug 
loaded SA/PEG/KA microbeads (d) and KA (e) 
3.5. XRD Analysis 
X-ray diffraction studies were performed to investigate the 
crystalline behaviour of CUR and also confirm the 
intercalation of CUR with KA in the polymer network. The 
XRD patterns of CUR (a), placebo microbeads (b), drug 
loaded SA/PEG microbeads (c), KA (d) and drug loaded 
SA/PEG/KA microbeads (e) are displayed in Fig. 5. The most 
intensive peaks of CUR (Fig. 5a) were observed in the ʹθ 
region of 12-28o suggesting its crystalline nature. But these 
peaks are not observed in drug loaded SA/PEG microbeads 
due to the absence of CUR crystals in the drug loaded 
SA/PEG (Fig. 5c) microbeads, hence confirmed that CUR is 
molecularly dispersed in the polymeric network. The XRD 
pattern of KA (Fig. 5.d) shows a characteristic peaks at 
11.90o, 20.69o and 24.46o indicates the presence of kaoline. 
The peak at 26.60o confirms the presence of traces of quartz. 
The XRD pattern of drug loaded SA/PEG microbeads shows 
peaks at 12.52o and 20.25o which confirmed that the drug 
was intercalated with KA. 
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Fig.5. XRD patterns of CUR (a), placebo microbeads (b), drug loaded SA/PEG microbeads (SP3 Formulation) (c), KA (d) and 
drug loaded SA/PEG/KA microbeads (e) 
3.6. SEM Analysis 
Fig. 6 illustrates the topographical images of microbeads 
obtained under different blend polymer ratios. The outer 
surface of microbeads shows rough surface with visible 
wrinkles. It was interesting to see that more porous nature 
was observed in SP1 (Fig. 6a) due to formation of less rigid 
network of sodium alginate network. Whereas the 
formulations SP2 (Fig. 6b) and SP7 (Fig. 6d) shows less 
porous nature due to formation of rigid polymer network of 
SA/PEG. Fig. 6c shows the scanning electron micrograph of 
SP6, it was observed the outer surface was more rigid with 
rough surface, this confirmed the presence of KA platelets in 
the polymer network. From the results of SEM images, the bead size was measured as ͳͲͲͲ to ͳ͵ͲͲ Ɋm. 
 
 
Fig. 6. SEM images of SP1 (a), SP2 (b), SP6 (c) and SP7 (d) microbeads 
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3.7. EDS Analysis 
To find out the elemental composition of SP2 and SP6 
formulations, EDS analysis were performed and the results 
are displayed in Fig. 7. The EDS spectra of SP2 (Fig. 7a) 
shows C, O, Na, Cl and Ca peaks, whereas these similar peaks 
were observed in SP7 (Fig. 7b), but along with these peaks 
Al, Si and K peaks were observed in SP7, which confirmed 
the  presence of KA in microbeads. 
 
 
Fig. 7. EDS spectra of drug loaded SA/PEG microbeads (a) and drug loaded SA/PEG/KA microbeads (b) 
3.8. Swelling measurements 
Swelling degree is one of the most important factors of 
polymeric hydrogel beads for biomedical applications, 
because they show strong influence on diffusion of oxygen, 
drugs, nutrients and other water soluble metabolites. In 
order to investigate the swelling degree of microbeads, 
swelling experiments were performed in both pH 1.2 and 7.4 
at 37oC and the results are displayed in Fig. 8. From the Fig. 
8a and b, it was observed that the swelling degree was more 
in pH 7.4 than the pH 1.2. This is due to at pH 1.2 hydrogen 
bonding interactions were developed between –COOH 
groups of polymeric chains and solvent molecules resulting 
shrinking of network consequently the swelling ratio was 
observed to decrease34. While at pH 7.4 the carboxylic 
groups repel the water molecules because of the existence of 
ionic repulsions resulting the increasing of swelling degree. 
Therefore the developed beads are good promising carriers 
to deliver drug molecules at intestine and to avoid gastric 
release of drugs. 
At pH 7.4 the swelling degree of all formulations was 
different due to the variation in blend composition of 
polymer network. From Fig. 8a, it was observed that 
swelling degree was decreased with the increase of PEG 
content in polymer network. This can be clarified by the SEM 
results. From the SEM studies it was observed that the 
porous nature was decreased with increase of PEG content 
in the polymer network. If the porous nature increases 
therefore it can accommodate more amount of water in their 
pores resulting in higher swelling degree. The swelling 
degree of SP4, SP5 and SP6 decreases with the increase of 
KA content in polymer network, this due to the formation of 
more rigid network, which restricted the inward flow of 
solvent molecules, resulting lower swelling degree. 
 
 
Fig. 8.a. Swelling studies in pH 7.4 at 37oC 
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Fig. 8.b. Swelling studies in pH 1.2 at 37oC 
3.9. Encapsulation Efficiency (%EE) 
Encapsulation efficiency of drug loaded microbeads varied 
for all formulations due to variation in blend composition of 
polymer matrix and the results are listed in Table 2. The 
%EE was decreased with increase of PEG content in the 
polymer due to formation of more rigid network, thereby 
swell to less extent, which results low %EE values. This effect 
was observed in formulations of SP1, SP2 and SP3. As the 
concentration of KA increases in the polymer network %EE 
also increases this is due to KA has large specific area in its 
structure,  good absorption capacity and develops hydrogen 
bonding between CUR and hydroxyl groups of KA. 
3.10. In Vitro Drug Release Studies 
The in vitro release studies of CUR from the microbeads 
were carried out under both pH 1.2 and 7.4 medium 
conditions and the release profiles for all formulations are 
displayed in Fig. 9a and b. The release data at pH 7.4 showed 
high release rate and avoid its release in acidic conditions pH 
1.2. this is due to at pH 7.4, the carboxylate groups have less 
interactions with buffer medium therefore the network 
becomes more slack, hence the entrapped drug molecules 
easily leached out from the network. The obtained in vitro 
release results are correlated with the swelling results has 
previously discussed in this work. 
At pH 7.4, the release rate was different for all profiles, this 
can be explained based on the composition of polymer 
network. The drug release profiles of SP1, SP2 and SP3 
decreases as the content of PEG increases, this is due to formation of rigid network, hence CUR particles haven’t 
chance to escape from the polymer network. The release rate 
of SP4, SP5 and SP6 decreases with the increase of KA 
content, this is due to the intercalated drug molecules cannot 
be exchanged completely in ion exchange process with 
phosphate ions of the buffer solution which leads to 
incomplete release process. 
To understand the drug release mechanism of CUR from the 
blend microbeads, the in vitro release data was fitted in to 
the following Korsmeyer-Peppas kinetic equation      = ktn 
where Mt/MȽ is a fraction of the drug released at time t, k is 
the rate constant, and n is the release exponent which 
represents the release mechanism. The values of n are 
obtained in the range of 0487-0.529 and the values are listed 
Table 2, the results suggesting that the release followed non-
Fickian type diffusion process. 
 
Fig. 9.a. % CUR release in pH 7.4 at 37 oC 
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Fig. 9.b. % CUR release in pH 1.2 at 37 oC 
Table 2. Release kinetics parameters at pH-7.4 and encapsulation efficiency (%EE) of all samples 
Formulation code 
 pH 7.4 
%EE 
r2 n k 
SP1 0.942 0.524 0.1398 45.16 
SP2 0.948 0.517 0.1216 42.21 
SP3 0.961 0.529 0.0950 40.32 
SP4 0.958 0.483 0.0845 43.41 
SP5 0.962 0.498 0.0818 46.32 
SP6 0.970 0.487 0.0608 49.51 
 
 
4.0. CONCLUSION 
In this study, we fabricated CUR encapsulated semi IPN 
micro beads from SA/PEG/KA through simple ionotropic 
gelation method.  The developed microbeads were confirmed 
by FTIR spectroscopy. Thermal stability and molecular level 
dispersion of CUR in microbeads were confirmed by TGA and 
DSC respectively. Intercalation of CUR with KA was 
confirmed by XRD studies. From the SEM pictures it was 
observed that the microbeads are spherical in shape and 
wrinkled surface with few depressions on the surface and 
also it confirmed the presence of KA platelets on outer 
surface of microbeads. From the SEM results the average diameter of microbeads was found to be ͳͲͲͲ to ͳ͵ͲͲ Ɋm. 
The dynamic swelling studies were depended on the blend 
composition and pH of the medium. Swelling degree was 
decreased with the increase of PEG and KA content in 
polymer network. The in vitro release studies were 
performed in both pH 1.2 and 7.4 at 37oC and the results 
were fitted into peppas equation, which confirmed that the 
maximum % CUR release (96%) was achieved to 42 h via 
diffusion controlled non-Fickian transport. 
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